var eventsData = [{"Ticker":"CCL","EffectiveDate":"2016-12-20","Type":"EarningsRelease","Title":"Before market open, CCL reports 2016 Q4's earning $0.67 per share and revenue $3935MM..","DailyReturn":"2.27%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"-1.56%"},{"Ticker":"CCL","EffectiveDate":"2016-12-19","Type":"RatingNeutral","Title":"Berenberg downgrades CCL to Hold from Buy.","DailyReturn":"-0.34%","FiveDayReturnAfter":"2.92%","FiveDayReturnBefore":"-3.51%"},{"Ticker":"CCL","EffectiveDate":"2016-12-16","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on CCL to Neutral.","DailyReturn":"-2.75%","FiveDayReturnAfter":"-1.04%","FiveDayReturnBefore":"0.07%"},{"Ticker":"CCL","EffectiveDate":"2016-11-23","Type":"RatingUpgrade","Title":"Bernstein upgrades CCL to Outperform from Market Perform. Target Price is $63; previously $52.","DailyReturn":"1.02%","FiveDayReturnAfter":"-0.69%","FiveDayReturnBefore":"2.24%"},{"Ticker":"CCL","EffectiveDate":"2016-11-22","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":"1.68%","FiveDayReturnAfter":"4.43%","FiveDayReturnBefore":"0.94%"},{"Ticker":"CCL","EffectiveDate":"2016-11-22","Type":"RatingUpgrade","Title":null,"DailyReturn":"1.68%","FiveDayReturnAfter":"4.43%","FiveDayReturnBefore":"0.94%"},{"Ticker":"CCL","EffectiveDate":"2016-10-04","Type":"RatingNeutral","Title":"Macquarie initiates coverage on CCL to Neutral.","DailyReturn":"0.12%","FiveDayReturnAfter":"-3.35%","FiveDayReturnBefore":"5.56%"},{"Ticker":"CCL","EffectiveDate":"2016-10-03","Type":"RatingNeutral","Title":"HSBC initiates coverage on CCL to Buy. Target Price is $60.","DailyReturn":"0.63%","FiveDayReturnAfter":"-2.21%","FiveDayReturnBefore":"3.24%"},{"Ticker":"CCL","EffectiveDate":"2016-09-29","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on CCL to Hold. Target Price is $48.","DailyReturn":"-1.06%","FiveDayReturnAfter":"-0.02%","FiveDayReturnBefore":"6.26%"},{"Ticker":"CCL","EffectiveDate":"2016-09-27","Type":"RatingNeutral","Title":"Buckingham Research maintains CCL to Buy. Target Price is $55; previously $53.","DailyReturn":"4.04%","FiveDayReturnAfter":"5.56%","FiveDayReturnBefore":"1.23%"},{"Ticker":"CCL","EffectiveDate":"2016-09-26","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2016 Q3's earning $1.92 per share and revenue $5097MM. This beats analyst's estimated EPS $1.88, beats estimated revenue $5060MM.","DailyReturn":"-1.67%","FiveDayReturnAfter":"3.24%","FiveDayReturnBefore":"2.16%"},{"Ticker":"CCL","EffectiveDate":"2016-09-09","Type":"RatingNeutral","Title":"Bernstein initiates coverage on CCL to Outperform. Target Price is $51.","DailyReturn":"-1.09%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-6.34%"},{"Ticker":"CCL","EffectiveDate":"2016-09-02","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CCL to Underweight from Equal-Weight. Target Price is $48; previously $54.","DailyReturn":"-4.74%","FiveDayReturnAfter":"-9.31%","FiveDayReturnBefore":"3.14%"},{"Ticker":"CCL","EffectiveDate":"2016-08-24","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":"-0.31%","FiveDayReturnAfter":"-0.06%","FiveDayReturnBefore":"2.56%"},{"Ticker":"CCL","EffectiveDate":"2016-06-29","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $52; previously $46.5.","DailyReturn":"1.69%","FiveDayReturnAfter":"-1.26%","FiveDayReturnBefore":"-10.66%"},{"Ticker":"CCL","EffectiveDate":"2016-06-28","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2016 Q2's earning $0.49 per share and revenue $3705MM. This beats analyst's estimated EPS $0.38, beats estimated revenue $3680MM.","DailyReturn":"0.2%","FiveDayReturnAfter":"0.25%","FiveDayReturnBefore":"-10.55%"},{"Ticker":"CCL","EffectiveDate":"2016-06-07","Type":"RatingNeutral","Title":"Sterne Agee CRT initiates coverage on CCL to Buy. Target Price is $60.","DailyReturn":"0.91%","FiveDayReturnAfter":"-0.91%","FiveDayReturnBefore":"-3.19%"},{"Ticker":"CCL","EffectiveDate":"2016-05-31","Type":"RatingUpgrade","Title":"Tigress Financial upgrades CCL to Buy from Neutral.","DailyReturn":"-1.76%","FiveDayReturnAfter":"-3.19%","FiveDayReturnBefore":"-2.2%"},{"Ticker":"CCL","EffectiveDate":"2016-05-26","Type":"RatingNeutral","Title":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $54; previously $60.","DailyReturn":"-4.11%","FiveDayReturnAfter":"-2.65%","FiveDayReturnBefore":"-0.7%"},{"Ticker":"CCL","EffectiveDate":"2016-05-25","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":"-1.68%","FiveDayReturnAfter":"-4.93%","FiveDayReturnBefore":"1.78%"},{"Ticker":"CCL","EffectiveDate":"2016-04-08","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $60; previously $58.","DailyReturn":"-0.07%","FiveDayReturnAfter":"0.75%","FiveDayReturnBefore":"-3.05%"},{"Ticker":"CCL","EffectiveDate":"2016-04-07","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $60; previously $58.","DailyReturn":"-1.55%","FiveDayReturnAfter":"-0.59%","FiveDayReturnBefore":"-0.72%"},{"Ticker":"CCL","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"JP Morgan maintains CCL to Neutral. Target Price is $58; previously $57.","DailyReturn":"0.76%","FiveDayReturnAfter":"-0.72%","FiveDayReturnBefore":"7.16%"},{"Ticker":"CCL","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CCL to Buy. Target Price is $60; previously $59.","DailyReturn":"0.76%","FiveDayReturnAfter":"-0.72%","FiveDayReturnBefore":"7.16%"},{"Ticker":"CCL","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $58; previously $57.","DailyReturn":"0.76%","FiveDayReturnAfter":"-0.72%","FiveDayReturnBefore":"7.16%"},{"Ticker":"CCL","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $53.5; previously $52.5.","DailyReturn":"0.76%","FiveDayReturnAfter":"-0.72%","FiveDayReturnBefore":"7.16%"},{"Ticker":"CCL","EffectiveDate":"2016-03-29","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $52.5; previously $49.5.","DailyReturn":"1.26%","FiveDayReturnAfter":"7.86%","FiveDayReturnBefore":"-1.23%"},{"Ticker":"CCL","EffectiveDate":"2016-02-29","Type":"RatingNeutral","Title":"Credit Suisse assumes CCL to Outperform. Target Price is $60.","DailyReturn":"-0.78%","FiveDayReturnAfter":"-0.76%","FiveDayReturnBefore":"4.11%"},{"Ticker":"CCL","EffectiveDate":"2016-02-17","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":"2.68%","FiveDayReturnAfter":"7.28%","FiveDayReturnBefore":"7.13%"},{"Ticker":"CCL","EffectiveDate":"2016-01-04","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $60; previously $55.3.","DailyReturn":"-0.51%","FiveDayReturnAfter":"-4.56%","FiveDayReturnBefore":"0.73%"},{"Ticker":"CCL","EffectiveDate":"2015-12-21","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $57; previously $54.","DailyReturn":"2.91%","FiveDayReturnAfter":"3.33%","FiveDayReturnBefore":"3.33%"},{"Ticker":"CCL","EffectiveDate":"2015-12-21","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CCL to Buy. Target Price is $59; previously $55.","DailyReturn":"2.91%","FiveDayReturnAfter":"3.33%","FiveDayReturnBefore":"3.33%"},{"Ticker":"CCL","EffectiveDate":"2015-12-18","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCL reports 2015 Q4's earning $0.5 per share and revenue $3711MM. This beats analyst's estimated EPS $0.42, misses estimated revenue $3720MM.","DailyReturn":"3.86%","FiveDayReturnAfter":"7%","FiveDayReturnBefore":"-0.98%"},{"Ticker":"CCL","EffectiveDate":"2015-11-25","Type":"RatingNeutral","Title":"HSBC initiates coverage on CCL to Buy. Target Price is $60.","DailyReturn":"1.19%","FiveDayReturnAfter":"1.55%","FiveDayReturnBefore":"0.91%"},{"Ticker":"CCL","EffectiveDate":"2015-11-18","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":"0.72%","FiveDayReturnAfter":"0.91%","FiveDayReturnBefore":"-5.61%"},{"Ticker":"CCL","EffectiveDate":"2015-11-04","Type":"RatingNeutral","Title":"Buckingham Research maintains CCL to Buy. Target Price is $60; previously $65.","DailyReturn":"-0.33%","FiveDayReturnAfter":"0.28%","FiveDayReturnBefore":"-1.61%"},{"Ticker":"CCL","EffectiveDate":"2015-10-05","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $57; previously $58.","DailyReturn":"1.24%","FiveDayReturnAfter":"-0.8%","FiveDayReturnBefore":"-1.87%"},{"Ticker":"CCL","EffectiveDate":"2015-09-23","Type":"RatingUpgrade","Title":"Nomura upgrades CCL to Buy from Neutral. Target Price is $62; previously $53.","DailyReturn":"3.43%","FiveDayReturnAfter":"-3.18%","FiveDayReturnBefore":"-4.22%"},{"Ticker":"CCL","EffectiveDate":"2015-09-23","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $61; previously $60.","DailyReturn":"3.43%","FiveDayReturnAfter":"-3.18%","FiveDayReturnBefore":"-4.22%"},{"Ticker":"CCL","EffectiveDate":"2015-09-21","Type":"RatingNeutral","Title":"Susquehanna maintains CCL to Positive. Target Price is $60; previously $56.","DailyReturn":"1.17%","FiveDayReturnAfter":"-2.66%","FiveDayReturnBefore":"1.33%"},{"Ticker":"CCL","EffectiveDate":"2015-09-18","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $53; previously $48.","DailyReturn":"-1.27%","FiveDayReturnAfter":"-3.59%","FiveDayReturnBefore":"3.9%"},{"Ticker":"CCL","EffectiveDate":"2015-08-19","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":"-0.38%","FiveDayReturnAfter":"-10.34%","FiveDayReturnBefore":"1.16%"},{"Ticker":"CCL","EffectiveDate":"2015-07-14","Type":"RatingUpgrade","Title":"Jefferies upgrades CCL to Hold from Underperform.","DailyReturn":"0.71%","FiveDayReturnAfter":"0.61%","FiveDayReturnBefore":"4.88%"},{"Ticker":"CCL","EffectiveDate":"2015-07-09","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $58; previously $56.","DailyReturn":"0.55%","FiveDayReturnAfter":"5.77%","FiveDayReturnBefore":"-0.93%"},{"Ticker":"CCL","EffectiveDate":"2015-06-24","Type":"RatingNeutral","Title":"Buckingham Research maintains CCL to Buy. Target Price is $60; previously $58.","DailyReturn":"0.72%","FiveDayReturnAfter":"-0.18%","FiveDayReturnBefore":"4.18%"},{"Ticker":"CCL","EffectiveDate":"2015-06-24","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CCL to Buy. Target Price is $55; previously $53.","DailyReturn":"0.72%","FiveDayReturnAfter":"-0.18%","FiveDayReturnBefore":"4.18%"},{"Ticker":"CCL","EffectiveDate":"2015-06-24","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $60; previously $55.","DailyReturn":"0.72%","FiveDayReturnAfter":"-0.18%","FiveDayReturnBefore":"4.18%"},{"Ticker":"CCL","EffectiveDate":"2015-06-22","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades CCL to Buy from Hold. Target Price is $55.3; previously $51.","DailyReturn":"2.04%","FiveDayReturnAfter":"3.37%","FiveDayReturnBefore":"3.11%"},{"Ticker":"CCL","EffectiveDate":"2015-06-19","Type":"RatingNeutral","Title":"Susquehanna maintains CCL to Positive. Target Price is $56; previously $55.","DailyReturn":"0.61%","FiveDayReturnAfter":"2.87%","FiveDayReturnBefore":"1.63%"},{"Ticker":"CCL","EffectiveDate":"2015-05-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-1.22%","FiveDayReturnAfter":"-1.08%","FiveDayReturnBefore":"5.43%"},{"Ticker":"CCL","EffectiveDate":"2015-05-13","Type":"RatingUpgrade","Title":"SunTrust Robinson Humphrey upgrades CCL to Buy from Neutral.","DailyReturn":"-0.06%","FiveDayReturnAfter":"5.43%","FiveDayReturnBefore":"5.38%"},{"Ticker":"CCL","EffectiveDate":"2015-04-29","Type":"RatingUpgrade","Title":"Tigress Financial upgrades CCL to Neutral from Underperform.","DailyReturn":"-2.24%","FiveDayReturnAfter":"-4.54%","FiveDayReturnBefore":"-2.54%"},{"Ticker":"CCL","EffectiveDate":"2015-04-13","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CCL to Neutral. Target Price is $53; previously $52.","DailyReturn":"-1.03%","FiveDayReturnAfter":"-2.76%","FiveDayReturnBefore":"0.74%"},{"Ticker":"CCL","EffectiveDate":"2015-04-07","Type":"RatingUpgrade","Title":"Wells Fargo upgrades CCL to Outperform from Market Perform.","DailyReturn":"1.98%","FiveDayReturnAfter":"0.14%","FiveDayReturnBefore":"1.34%"},{"Ticker":"CCL","EffectiveDate":"2015-03-30","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Outperform. Target Price is $55; previously $52.","DailyReturn":"1.27%","FiveDayReturnAfter":"1.34%","FiveDayReturnBefore":"0.51%"},{"Ticker":"CCL","EffectiveDate":"2015-03-30","Type":"RatingUpgrade","Title":"Numis Securities upgrades CCL to Add from Hold.","DailyReturn":"1.27%","FiveDayReturnAfter":"1.34%","FiveDayReturnBefore":"0.51%"},{"Ticker":"CCL","EffectiveDate":"2015-03-23","Type":"RatingNeutral","Title":"Deutsche Bank downgrades CCL to Hold from Buy. Target Price is $51; previously $48.","DailyReturn":"-1.74%","FiveDayReturnAfter":"0.51%","FiveDayReturnBefore":"3.36%"},{"Ticker":"CCL","EffectiveDate":"2015-03-20","Type":"RatingNeutral","Title":"Wedbush initiates coverage on CCL to Neutral. Target Price is $52.","DailyReturn":"0.42%","FiveDayReturnAfter":"-4.96%","FiveDayReturnBefore":"3.02%"},{"Ticker":"CCL","EffectiveDate":"2015-02-18","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"1.92%","FiveDayReturnAfter":"1.26%","FiveDayReturnBefore":"1.48%"},{"Ticker":"CCL","EffectiveDate":"2015-01-12","Type":"RatingNeutral","Title":"Natixis downgrades CCL to Neutral from Buy.","DailyReturn":"-0.02%","FiveDayReturnAfter":"-1.83%","FiveDayReturnBefore":"1.5%"},{"Ticker":"CCL","EffectiveDate":"2014-12-22","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $54; previously $52.","DailyReturn":"0.15%","FiveDayReturnAfter":"2.55%","FiveDayReturnBefore":"4.19%"},{"Ticker":"CCL","EffectiveDate":"2014-12-17","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $48; previously $46.","DailyReturn":"3.45%","FiveDayReturnAfter":"4.93%","FiveDayReturnBefore":"-1.95%"},{"Ticker":"CCL","EffectiveDate":"2014-12-08","Type":"RatingNeutral","Title":"Jefferies maintains CCL to Underperform. Target Price is $36; previously $33.","DailyReturn":"-1.23%","FiveDayReturnAfter":"-3.81%","FiveDayReturnBefore":"1.03%"},{"Ticker":"CCL","EffectiveDate":"2014-12-05","Type":"RatingNeutral","Title":"Bank of America maintains CCL to Buy. Target Price is $53; previously $49.","DailyReturn":"2.38%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"3.4%"},{"Ticker":"CCL","EffectiveDate":"2014-12-01","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CCL to Neutral from Buy.","DailyReturn":"-4%","FiveDayReturnAfter":"1.03%","FiveDayReturnBefore":"5.97%"},{"Ticker":"CCL","EffectiveDate":"2014-11-19","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-1.02%","FiveDayReturnAfter":"0.56%","FiveDayReturnBefore":"3.95%"},{"Ticker":"CCL","EffectiveDate":"2014-09-24","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Outperform. Target Price is $46; previously $43.","DailyReturn":"1.5%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"2.52%"},{"Ticker":"CCL","EffectiveDate":"2014-09-24","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $52; previously $49.","DailyReturn":"1.5%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"2.52%"},{"Ticker":"CCL","EffectiveDate":"2014-09-24","Type":"RatingNeutral","Title":"Bank of America maintains CCL to Buy. Target Price is $49; previously $45.5.","DailyReturn":"1.5%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"2.52%"},{"Ticker":"CCL","EffectiveDate":"2014-09-23","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2014 Q3's earning $1.58 per share and revenue $4950MM. This beats analyst's estimated EPS $1.44, beats estimated revenue $4930MM.","DailyReturn":"0.42%","FiveDayReturnAfter":"0.14%","FiveDayReturnBefore":"2.33%"},{"Ticker":"CCL","EffectiveDate":"2014-09-12","Type":"RatingUpgrade","Title":"Shore Capital upgrades CCL to Buy from Hold.","DailyReturn":"-0.25%","FiveDayReturnAfter":"2.09%","FiveDayReturnBefore":"0.48%"},{"Ticker":"CCL","EffectiveDate":"2014-08-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"0.5%","FiveDayReturnAfter":"1.21%","FiveDayReturnBefore":"2.27%"},{"Ticker":"CCL","EffectiveDate":"2014-08-07","Type":"RatingUpgrade","Title":"Bank of America upgrades CCL to Buy from Neutral.","DailyReturn":"0.22%","FiveDayReturnAfter":"2.12%","FiveDayReturnBefore":"-0.87%"},{"Ticker":"CCL","EffectiveDate":"2014-06-23","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2014 Q2's earning $0.1 per share and revenue $3630MM. This beats analyst's estimated EPS $0.02, beats estimated revenue $3610MM.","DailyReturn":"0.76%","FiveDayReturnAfter":"-3.03%","FiveDayReturnBefore":"0.48%"},{"Ticker":"CCL","EffectiveDate":"2014-05-21","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"1.69%","FiveDayReturnAfter":"1.5%","FiveDayReturnBefore":"-0.43%"},{"Ticker":"CCL","EffectiveDate":"2014-05-20","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades CCL to Equal-weight from Underweight.","DailyReturn":"0.87%","FiveDayReturnAfter":"2.7%","FiveDayReturnBefore":"-2.31%"},{"Ticker":"CCL","EffectiveDate":"2014-04-29","Type":"RatingNeutral","Title":"Berenberg initiates coverage on CCL to Buy. Target Price is $50.","DailyReturn":"2.38%","FiveDayReturnAfter":"0.74%","FiveDayReturnBefore":"3.66%"},{"Ticker":"CCL","EffectiveDate":"2014-03-26","Type":"RatingNeutral","Title":"JP Morgan maintains CCL to Neutral. Target Price is $39; previously $38.","DailyReturn":"-0.99%","FiveDayReturnAfter":"0.99%","FiveDayReturnBefore":"-4.09%"},{"Ticker":"CCL","EffectiveDate":"2014-03-26","Type":"RatingNeutral","Title":"Bank of America maintains CCL to Neutral. Target Price is $42.9; previously $43.6.","DailyReturn":"-0.99%","FiveDayReturnAfter":"0.99%","FiveDayReturnBefore":"-4.09%"},{"Ticker":"CCL","EffectiveDate":"2014-03-25","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2014 Q1's earning $0 per share and revenue $3585MM. This beats analyst's estimated EPS $-0.08, beats estimated revenue $3560MM.","DailyReturn":"-4.95%","FiveDayReturnAfter":"-5.49%","FiveDayReturnBefore":"2.99%"},{"Ticker":"CCL","EffectiveDate":"2014-03-20","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $49; previously $48.","DailyReturn":"1.57%","FiveDayReturnAfter":"-4.49%","FiveDayReturnBefore":"0.17%"},{"Ticker":"CCL","EffectiveDate":"2014-02-27","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $48; previously $43.","DailyReturn":"0.57%","FiveDayReturnAfter":"-2.36%","FiveDayReturnBefore":"2.61%"},{"Ticker":"CCL","EffectiveDate":"2014-02-19","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-0.83%","FiveDayReturnAfter":"1.43%","FiveDayReturnBefore":"-1.37%"},{"Ticker":"CCL","EffectiveDate":"2014-02-11","Type":"RatingNeutral","Title":"Jefferies downgrades CCL to Underperform from Hold. Target Price is $33; previously $31.","DailyReturn":"-0.07%","FiveDayReturnAfter":"-1.37%","FiveDayReturnBefore":"3.94%"},{"Ticker":"CCL","EffectiveDate":"2014-02-05","Type":"RatingUpgrade","Title":"HSBC upgrades CCL to Overweight from Neutral. Target Price is $43.5; previously $33.","DailyReturn":"-1.1%","FiveDayReturnAfter":"3.1%","FiveDayReturnBefore":"-3.86%"},{"Ticker":"CCL","EffectiveDate":"2014-01-28","Type":"RatingUpgrade","Title":"Numis Securities upgrades CCL to Buy from Hold.","DailyReturn":"3.09%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"-4.93%"},{"Ticker":"CCL","EffectiveDate":"2014-01-13","Type":"RatingUpgrade","Title":"SunTrust Robinson Humphrey upgrades CCL to Neutral from Reduce.","DailyReturn":"0.41%","FiveDayReturnAfter":"0.26%","FiveDayReturnBefore":"3.45%"},{"Ticker":"CCL","EffectiveDate":"2013-12-20","Type":"RatingUpgrade","Title":"Credit Suisse upgrades CCL to Outperform from Neutral. Target Price is $43; previously $30.","DailyReturn":"2.1%","FiveDayReturnAfter":"4.72%","FiveDayReturnBefore":"7.38%"},{"Ticker":"CCL","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $43; previously $41.","DailyReturn":"2.1%","FiveDayReturnAfter":"4.72%","FiveDayReturnBefore":"7.38%"},{"Ticker":"CCL","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Nomura maintains CCL to Neutral. Target Price is $36; previously $32.","DailyReturn":"2.1%","FiveDayReturnAfter":"4.72%","FiveDayReturnBefore":"7.38%"},{"Ticker":"CCL","EffectiveDate":"2013-12-20","Type":"RatingUpgrade","Title":"Natixis upgrades CCL to Neutral from Reduce.","DailyReturn":"2.1%","FiveDayReturnAfter":"4.72%","FiveDayReturnBefore":"7.38%"},{"Ticker":"CCL","EffectiveDate":"2013-12-19","Type":"EarningsRelease","Title":"Before market open, CCL reports 2013 Q4's earning $0.09 per share and revenue $3658MM..","DailyReturn":"2.53%","FiveDayReturnAfter":"6.34%","FiveDayReturnBefore":"4.77%"},{"Ticker":"CCL","EffectiveDate":"2013-12-19","Type":"RatingUpgrade","Title":"UBS upgrades CCL to Buy from Neutral.","DailyReturn":"2.53%","FiveDayReturnAfter":"6.34%","FiveDayReturnBefore":"4.77%"},{"Ticker":"CCL","EffectiveDate":"2013-12-06","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $41; previously $42.","DailyReturn":"1%","FiveDayReturnAfter":"0.99%","FiveDayReturnBefore":"-3.37%"},{"Ticker":"CCL","EffectiveDate":"2013-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"1.1%","FiveDayReturnAfter":"1.68%","FiveDayReturnBefore":"-0.16%"},{"Ticker":"CCL","EffectiveDate":"2013-10-04","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on CCL to Reduce. Target Price is $26.","DailyReturn":"0.21%","FiveDayReturnAfter":"-1.55%","FiveDayReturnBefore":"-1.74%"},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Natixis downgrades CCL to Reduce from Neutral.","DailyReturn":"-5.32%","FiveDayReturnAfter":"-5.84%","FiveDayReturnBefore":"-8.54%"},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $39; previously $40.","DailyReturn":"-5.32%","FiveDayReturnAfter":"-5.84%","FiveDayReturnBefore":"-8.54%"},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CCL to Underweight from Equal-Weight. Target Price is $32.","DailyReturn":"-5.32%","FiveDayReturnAfter":"-5.84%","FiveDayReturnBefore":"-8.54%"},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Buy. Target Price is $40; previously $44.","DailyReturn":"-5.32%","FiveDayReturnAfter":"-5.84%","FiveDayReturnBefore":"-8.54%"},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Numis Securities downgrades CCL to Hold from Add.","DailyReturn":"-5.32%","FiveDayReturnAfter":"-5.84%","FiveDayReturnBefore":"-8.54%"},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Nomura maintains CCL to Neutral. Target Price is $32; previously $36.","DailyReturn":"-5.32%","FiveDayReturnAfter":"-5.84%","FiveDayReturnBefore":"-8.54%"},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Bank of America downgrades CCL to Neutral from Buy. Target Price is $38.5; previously $42.8.","DailyReturn":"-5.32%","FiveDayReturnAfter":"-5.84%","FiveDayReturnBefore":"-8.54%"},{"Ticker":"CCL","EffectiveDate":"2013-09-25","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $42; previously $44.","DailyReturn":"-5.32%","FiveDayReturnAfter":"-5.84%","FiveDayReturnBefore":"-8.54%"},{"Ticker":"CCL","EffectiveDate":"2013-09-24","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2013 Q3's earning $1.38 per share and revenue $4730MM. This beats analyst's estimated EPS $1.3, beats estimated revenue $4650MM.","DailyReturn":"-7.64%","FiveDayReturnAfter":"-13.61%","FiveDayReturnBefore":"0.16%"},{"Ticker":"CCL","EffectiveDate":"2013-09-04","Type":"RatingUpgrade","Title":"Susquehanna upgrades CCL to Positive from Neutral.","DailyReturn":"-0.27%","FiveDayReturnAfter":"3.3%","FiveDayReturnBefore":"-4.08%"},{"Ticker":"CCL","EffectiveDate":"2013-08-21","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"1.44%","FiveDayReturnAfter":"1.82%","FiveDayReturnBefore":"-1.18%"},{"Ticker":"CCL","EffectiveDate":"2013-08-15","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CCL to Buy from Neutral. Target Price is $42; previously $31.","DailyReturn":"-0.59%","FiveDayReturnAfter":"-0.61%","FiveDayReturnBefore":"-0.24%"},{"Ticker":"CCL","EffectiveDate":"2013-08-02","Type":"RatingNeutral","Title":"Tigress Financial initiates coverage on CCL to Underperform.","DailyReturn":"-0.02%","FiveDayReturnAfter":"-2.09%","FiveDayReturnBefore":"2.14%"},{"Ticker":"CCL","EffectiveDate":"2013-07-30","Type":"RatingNeutral","Title":"Numis Securities downgrades CCL to Add from Buy.","DailyReturn":"-0.16%","FiveDayReturnAfter":"1.68%","FiveDayReturnBefore":"1.46%"},{"Ticker":"CCL","EffectiveDate":"2013-06-26","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $44; previously $40.","DailyReturn":"-0.31%","FiveDayReturnAfter":"-0.02%","FiveDayReturnBefore":"1.67%"},{"Ticker":"CCL","EffectiveDate":"2013-06-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCL reports 2013 Q2's earning $0.09 per share and revenue $3500MM. This beats analyst's estimated EPS $0.06, misses estimated revenue $3560MM.","DailyReturn":"5.02%","FiveDayReturnAfter":"4.21%","FiveDayReturnBefore":"-1.43%"},{"Ticker":"CCL","EffectiveDate":"2013-06-13","Type":"RatingUpgrade","Title":"Numis Securities upgrades CCL to Buy from Add.","DailyReturn":"3.66%","FiveDayReturnAfter":"3.3%","FiveDayReturnBefore":"1.6%"},{"Ticker":"CCL","EffectiveDate":"2013-05-30","Type":"RatingNeutral","Title":"Exane BNP Paribas downgrades CCL to Underperform from Neutral.","DailyReturn":"1.23%","FiveDayReturnAfter":"-2.75%","FiveDayReturnBefore":"-1.38%"},{"Ticker":"CCL","EffectiveDate":"2013-05-22","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-1.54%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"-4.02%"},{"Ticker":"CCL","EffectiveDate":"2013-05-22","Type":"RatingNeutral","Title":"HSBC downgrades CCL to Neutral from Overweight.","DailyReturn":"-1.54%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"-4.02%"},{"Ticker":"CCL","EffectiveDate":"2013-05-22","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $40; previously $42.","DailyReturn":"-1.54%","FiveDayReturnAfter":"-1.38%","FiveDayReturnBefore":"-4.02%"},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $40; previously $43.","DailyReturn":"-4.27%","FiveDayReturnAfter":"-6.05%","FiveDayReturnBefore":"1.51%"},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"Nomura maintains CCL to Neutral. Target Price is $36; previously $37.5.","DailyReturn":"-4.27%","FiveDayReturnAfter":"-6.05%","FiveDayReturnBefore":"1.51%"},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"HSBC downgrades CCL to Neutral from Market Outperform. Target Price is $37.5; previously $44.","DailyReturn":"-4.27%","FiveDayReturnAfter":"-6.05%","FiveDayReturnBefore":"1.51%"},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Neutral from Neutral. Target Price is $32; previously $34.","DailyReturn":"-4.27%","FiveDayReturnAfter":"-6.05%","FiveDayReturnBefore":"1.51%"},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"RS Platou Markets maintains CCL to Neutral. Target Price is $33; previously $38.","DailyReturn":"-4.27%","FiveDayReturnAfter":"-6.05%","FiveDayReturnBefore":"1.51%"},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"UBS downgrades CCL to Neutral from Buy.","DailyReturn":"-4.27%","FiveDayReturnAfter":"-6.05%","FiveDayReturnBefore":"1.51%"},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"William Blair downgrades CCL to Market Perform from Outperform.","DailyReturn":"-4.27%","FiveDayReturnAfter":"-6.05%","FiveDayReturnBefore":"1.51%"},{"Ticker":"CCL","EffectiveDate":"2013-05-21","Type":"RatingNeutral","Title":"Wells Fargo downgrades CCL to Market Perform from Outperform.","DailyReturn":"-4.27%","FiveDayReturnAfter":"-6.05%","FiveDayReturnBefore":"1.51%"},{"Ticker":"CCL","EffectiveDate":"2013-04-22","Type":"RatingNeutral","Title":"Nomura downgrades CCL to Neutral from Buy.","DailyReturn":"-0.68%","FiveDayReturnAfter":"3.15%","FiveDayReturnBefore":"-2.19%"},{"Ticker":"CCL","EffectiveDate":"2013-03-19","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $40; previously $44.","DailyReturn":"-2.09%","FiveDayReturnAfter":"-0.82%","FiveDayReturnBefore":"-4.94%"},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $35; previously $38.5.","DailyReturn":"-2.94%","FiveDayReturnAfter":"-2.63%","FiveDayReturnBefore":"-2.03%"},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Neutral. Target Price is $34; previously $35.","DailyReturn":"-2.94%","FiveDayReturnAfter":"-2.63%","FiveDayReturnBefore":"-2.03%"},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Nomura maintains CCL to Buy. Target Price is $42; previously $46.","DailyReturn":"-2.94%","FiveDayReturnAfter":"-2.63%","FiveDayReturnBefore":"-2.03%"},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Exane BNP Paribas downgrades CCL to Neutral from Outperform.","DailyReturn":"-2.94%","FiveDayReturnAfter":"-2.63%","FiveDayReturnBefore":"-2.03%"},{"Ticker":"CCL","EffectiveDate":"2013-03-18","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $42; previously $47.","DailyReturn":"-2.94%","FiveDayReturnAfter":"-2.63%","FiveDayReturnBefore":"-2.03%"},{"Ticker":"CCL","EffectiveDate":"2013-03-15","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCL reports 2013 Q1's earning $0.08 per share and revenue $3590MM. This beats analyst's estimated EPS $0.02, misses estimated revenue $3630MM.","DailyReturn":"-2.18%","FiveDayReturnAfter":"-6.05%","FiveDayReturnBefore":"-1.41%"},{"Ticker":"CCL","EffectiveDate":"2013-02-25","Type":"RatingNeutral","Title":"Credit Suisse maintains CCL to Neutral. Target Price is $35; previously $36.","DailyReturn":"-1.6%","FiveDayReturnAfter":"2.42%","FiveDayReturnBefore":"-5.84%"},{"Ticker":"CCL","EffectiveDate":"2013-02-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-2.28%","FiveDayReturnAfter":"-4.59%","FiveDayReturnBefore":"-5.87%"},{"Ticker":"CCL","EffectiveDate":"2013-01-14","Type":"RatingNeutral","Title":"Nomura maintains CCL to Buy. Target Price is $85; previously $75.","DailyReturn":"0.91%","FiveDayReturnAfter":"4.1%","FiveDayReturnBefore":"-0.08%"},{"Ticker":"CCL","EffectiveDate":"2013-01-07","Type":"RatingNeutral","Title":"UBS maintains CCL to Buy. Target Price is $43.37; previously $40.16.","DailyReturn":"-0.32%","FiveDayReturnAfter":"-0.08%","FiveDayReturnBefore":"0.97%"},{"Ticker":"CCL","EffectiveDate":"2012-12-24","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $38.5; previously $42.75.","DailyReturn":"0.16%","FiveDayReturnAfter":"-0.67%","FiveDayReturnBefore":"-1.87%"},{"Ticker":"CCL","EffectiveDate":"2012-12-20","Type":"EarningsRevenueBeat","Title":"Before market open, CCL reports 2012 Q4's earning $0.13 per share and revenue $3580MM. This beats analyst's estimated EPS $0.11, beats estimated revenue $3540MM.","DailyReturn":"-5.29%","FiveDayReturnAfter":"-6.23%","FiveDayReturnBefore":"3.09%"},{"Ticker":"CCL","EffectiveDate":"2012-12-19","Type":"RatingNeutral","Title":"RS Platou Markets maintains CCL to Neutral. Target Price is $44; previously $38.","DailyReturn":"-0.66%","FiveDayReturnAfter":"-7.16%","FiveDayReturnBefore":"3.81%"},{"Ticker":"CCL","EffectiveDate":"2012-12-12","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $47; previously $40.","DailyReturn":"0.05%","FiveDayReturnAfter":"3.81%","FiveDayReturnBefore":"1.51%"},{"Ticker":"CCL","EffectiveDate":"2012-12-05","Type":"Dividend","Title":"The Firm pays dividend $0.5","DailyReturn":"-0.18%","FiveDayReturnAfter":"1.51%","FiveDayReturnBefore":"-0.89%"},{"Ticker":"CCL","EffectiveDate":"2012-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"0.5%","FiveDayReturnAfter":"0.34%","FiveDayReturnBefore":"-0.57%"},{"Ticker":"CCL","EffectiveDate":"2012-11-07","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $48; previously $46.","DailyReturn":"-0.82%","FiveDayReturnAfter":"-1.44%","FiveDayReturnBefore":"2.91%"},{"Ticker":"CCL","EffectiveDate":"2012-10-01","Type":"RatingNeutral","Title":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $37; previously $34.","DailyReturn":"-1.12%","FiveDayReturnAfter":"1.9%","FiveDayReturnBefore":"-2.6%"},{"Ticker":"CCL","EffectiveDate":"2012-10-01","Type":"RatingNeutral","Title":"Barclays initiates coverage on CCL to Equal-Weight.","DailyReturn":"-1.12%","FiveDayReturnAfter":"1.9%","FiveDayReturnBefore":"-2.6%"},{"Ticker":"CCL","EffectiveDate":"2012-09-27","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCL to Neutral. Target Price is $38; previously $35.","DailyReturn":"-0.7%","FiveDayReturnAfter":"-0.51%","FiveDayReturnBefore":"-2.55%"},{"Ticker":"CCL","EffectiveDate":"2012-09-26","Type":"RatingNeutral","Title":"Nomura maintains CCL to Buy. Target Price is $42; previously $40.","DailyReturn":"-0.86%","FiveDayReturnAfter":"-2.54%","FiveDayReturnBefore":"-1.36%"},{"Ticker":"CCL","EffectiveDate":"2012-09-26","Type":"RatingNeutral","Title":"Jefferies downgrades CCL to Hold from Buy. Target Price is $37.5.","DailyReturn":"-0.86%","FiveDayReturnAfter":"-2.54%","FiveDayReturnBefore":"-1.36%"},{"Ticker":"CCL","EffectiveDate":"2012-09-26","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $36; previously $35.","DailyReturn":"-0.86%","FiveDayReturnAfter":"-2.54%","FiveDayReturnBefore":"-1.36%"},{"Ticker":"CCL","EffectiveDate":"2012-09-26","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $44; previously $42.","DailyReturn":"-0.86%","FiveDayReturnAfter":"-2.54%","FiveDayReturnBefore":"-1.36%"},{"Ticker":"CCL","EffectiveDate":"2012-09-25","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $40; previously $38.5.","DailyReturn":"0.21%","FiveDayReturnAfter":"-2.68%","FiveDayReturnBefore":"-1.71%"},{"Ticker":"CCL","EffectiveDate":"2012-09-25","Type":"EarningBeat","Title":"Before market open, CCL reports 2012 Q3's earning $1.53 per share and revenue $4680MM. This beats analyst's estimated EPS $1.44, meets estimated revenue $4680MM.","DailyReturn":"0.21%","FiveDayReturnAfter":"-2.68%","FiveDayReturnBefore":"-1.71%"},{"Ticker":"CCL","EffectiveDate":"2012-09-24","Type":"RatingNeutral","Title":"Topeka downgrades CCL to Hold from Buy. Target Price is $38.","DailyReturn":"-1.04%","FiveDayReturnAfter":"-2.6%","FiveDayReturnBefore":"-1.51%"},{"Ticker":"CCL","EffectiveDate":"2012-09-14","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCL to Buy. Target Price is $38.5; previously $37.5.","DailyReturn":"0.37%","FiveDayReturnAfter":"-0.58%","FiveDayReturnBefore":"5.12%"},{"Ticker":"CCL","EffectiveDate":"2012-08-22","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-0.75%","FiveDayReturnAfter":"1.81%","FiveDayReturnBefore":"1.77%"},{"Ticker":"CCL","EffectiveDate":"2012-06-25","Type":"RatingNeutral","Title":"UBS maintains CCL to Buy. Target Price is $40; previously $39.","DailyReturn":"-0.47%","FiveDayReturnAfter":"1.79%","FiveDayReturnBefore":"-3.21%"},{"Ticker":"CCL","EffectiveDate":"2012-06-25","Type":"RatingNeutral","Title":"Barclays maintains CCL to Equal-Weight. Target Price is $38; previously $30.","DailyReturn":"-0.47%","FiveDayReturnAfter":"1.79%","FiveDayReturnBefore":"-3.21%"},{"Ticker":"CCL","EffectiveDate":"2012-06-25","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCL to Buy. Target Price is $41; previously $35.","DailyReturn":"-0.47%","FiveDayReturnAfter":"1.79%","FiveDayReturnBefore":"-3.21%"},{"Ticker":"CCL","EffectiveDate":"2012-06-25","Type":"RatingNeutral","Title":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $34; previously $30.","DailyReturn":"-0.47%","FiveDayReturnAfter":"1.79%","FiveDayReturnBefore":"-3.21%"},{"Ticker":"CCL","EffectiveDate":"2012-06-22","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCL reports 2012 Q2's earning $0.2 per share and revenue $3500MM. This beats analyst's estimated EPS $0.08, misses estimated revenue $3550MM.","DailyReturn":"-2.66%","FiveDayReturnAfter":"-2.45%","FiveDayReturnBefore":"0.05%"},{"Ticker":"CCL","EffectiveDate":"2012-05-23","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"0.22%","FiveDayReturnAfter":"0.43%","FiveDayReturnBefore":"0.34%"},{"Ticker":"CCL","EffectiveDate":"2012-03-12","Type":"RatingNeutral","Title":"Citigroup maintains CCL to Buy. Target Price is $36; previously $39.","DailyReturn":"1.01%","FiveDayReturnAfter":"5.56%","FiveDayReturnBefore":"0%"},{"Ticker":"CCL","EffectiveDate":"2012-03-09","Type":"EarningsRelease","Title":"Before market open, CCL reports 2012 Q1's earning $-0.18 per share and revenue $3582MM..","DailyReturn":"-1.22%","FiveDayReturnAfter":"4.54%","FiveDayReturnBefore":"1.46%"},{"Ticker":"CCL","EffectiveDate":"2012-03-07","Type":"RatingNeutral","Title":"UBS maintains CCL to Buy. Target Price is $34; previously $35.","DailyReturn":"3.22%","FiveDayReturnAfter":"8.32%","FiveDayReturnBefore":"-1.78%"},{"Ticker":"CCL","EffectiveDate":"2012-03-01","Type":"RatingNeutral","Title":"Morgan Stanley maintains CCL to Equal-Weight. Target Price is $30; previously $27.","DailyReturn":"0.69%","FiveDayReturnAfter":"0.46%","FiveDayReturnBefore":"0.62%"},{"Ticker":"CCL","EffectiveDate":"2012-02-22","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-1.27%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"0.68%"},{"Ticker":"CCL","EffectiveDate":"2012-02-08","Type":"RatingNeutral","Title":"Charles Stanley downgrades CCL to Hold from Accumulate.","DailyReturn":"0.66%","FiveDayReturnAfter":"-4.33%","FiveDayReturnBefore":"5.13%"}];